53
Participants
Start Date
April 30, 2002
Primary Completion Date
August 31, 2003
epothilone b
EPO906 administered intravenously at 2.5 mg/m2 as a 5 minute bolus infusion repeated every week for three weeks followed by one week off The final tables and data is not in yet, so I cannot give you info on safety issues.
Our Lady Of Mercy Medical Center, The Bronx
University of Maryland, Baltimore
Cleveland Clinic Foundation, Cleveland
Wayne State University Karmanos Cancer Center, Detroit
UCLA Medical Center, Los Angeles
University of Washington, Seattle
Centre L. Berard, Lyon
Institut Gustave Roussy, Villejuif
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY